MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD)

Authors
SCHRIBER JR BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation
Jr. Schriber et al., MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 3786-3786
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
2
Supplement
1
Pages
3786 - 3786
Database
ISI
SICI code
0006-4971(1996)88:10<3786:MMDAC(>2.0.ZU;2-O